Trademark: 85599967
Word
ALLTRANZ
Status
Dead
Status Code
710
Status Date
Friday, February 12, 2021
Serial Number
85599967
Registration Number
4564661
Registration Date
Tuesday, July 8, 2014
Mark Type
4000
Filing Date
Tuesday, April 17, 2012
Published for Opposition
Tuesday, November 12, 2013
Cancellation Date
Friday, February 12, 2021

Trademark Owner History

Classifications
1 Chemicals for use in the manufacture of pharmaceuticals
5 Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, analgesics, anti-inflammatories, antiarthritic preparations, preparations for treating nausea and vertigo, preparations for the relief of pain and skin irritations, pharmaceutical preparations for enhancing topical penetration of drug delivery through the skin and mucous membranes; tranquilizers and psychotropics; medicated skin care preparations, namely, medicated skin creams, gels, antibiotic ointments and lotions for human and animal use; cleansing solutions for medical use, transdermal patches for use in the treatment of alcoholism, Alzheimer's disease, anorexia, anxiety disorders, appetite modulation, arthritis, cachexia, depression, drug addiction, inflammation, multiple sclerosis, neuralgia, neuropathic pain, obesity, opiate dependence, osteo-arthritis, pain, postsurgical pain, postherpetic neuralgia, seizure disorders, sleep disorders, and cerebrovascular disease; pharmaceutical preparations for the treatment of pain, substance addiction, substance abuse, muscle spasms, treatment of alcoholism, and treatment of neurodegeneration; veterinary products, namely, topical medicated treatments, namely, ointments, creams, solutions, gels, patches, poultices, and plasters for use in the relief of inflammation, arthritis, muscle spasms, pain, dermatitis and skin irritations; veterinary products, namely, pharmaceutical preparations for treating nausea and vertigo, cleansing solutions for medical use, transdermal patches for use in the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease; veterinary dermal and transdermal devices, namely, microneedles sold filled with medication for the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease, and for use in the relief of inflammation, arthritis, muscle spasms, pain, osteoarthritis pain, dermatitis and skin inflammation
42 Pharmaceutical research and development services

Trademark Events
Feb 12, 2021
Cancelled Sec. 8 (6-Yr)
Jul 8, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 14, 2018
Teas Change Of Correspondence Received
Dec 20, 2017
Automatic Update Of Assignment Of Ownership
Dec 6, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 6, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2014
Registered-Principal Register
Jun 6, 2014
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 5, 2014
Law Office Registration Review Completed
Jun 2, 2014
Assigned To Lie
Jun 1, 2014
Allowed Principal Register - Sou Accepted
May 3, 2014
Statement Of Use Processing Complete
Apr 11, 2014
Use Amendment Filed
Apr 30, 2014
Case Assigned To Intent To Use Paralegal
Apr 11, 2014
Teas Statement Of Use Received
Jan 7, 2014
Noa E-Mailed - Sou Required From Applicant
Nov 12, 2013
Official Gazette Publication Confirmation E-Mailed
Nov 12, 2013
Published For Opposition
Oct 23, 2013
Notification Of Notice Of Publication E-Mailed
Oct 4, 2013
Law Office Publication Review Completed
Sep 28, 2013
Assigned To Lie
Sep 17, 2013
Approved For Pub - Principal Register
Sep 11, 2013
Teas Change Of Correspondence Received
Sep 12, 2013
Teas/Email Correspondence Entered
Sep 12, 2013
Correspondence Received In Law Office
Sep 12, 2013
Teas Response To Office Action Received
Mar 19, 2013
Notification Of Non-Final Action E-Mailed
Mar 19, 2013
Non-Final Action E-Mailed
Mar 19, 2013
Non-Final Action Written
Feb 25, 2013
Examiner's Amendment Entered
Feb 25, 2013
Notification Of Examiners Amendment E-Mailed
Feb 25, 2013
Examiners Amendment E-Mailed
Feb 25, 2013
Examiners Amendment -Written
Feb 14, 2013
Teas Change Of Correspondence Received
Feb 14, 2013
Teas/Email Correspondence Entered
Feb 14, 2013
Correspondence Received In Law Office
Feb 14, 2013
Teas Response To Office Action Received
Feb 13, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 13, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 13, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 13, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 14, 2012
Notification Of Priority Action E-Mailed
Aug 14, 2012
Priority Action E-Mailed
Aug 14, 2012
Priority Action Written
Aug 1, 2012
Assigned To Examiner
Apr 24, 2012
New Application Office Supplied Data Entered In Tram
Apr 20, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24